Original filing (PDF)20241010091316NAL0020735585001

AVEO Pharmaceuticals, Inc.

Name: AVEO Pharmaceuticals, Inc. — AVEO Pharmaceuticals, Form 5500 (2023)
Creator: AVEO Pharmaceuticals, Inc.
License: https://www.usa.gov/government-works

Form 5500

FILING_RECEIVED

AVEO Pharmaceuticals Inc., 401(k) Plan

401(k) retirement plan · AVEO Pharmaceuticals, Inc.'s AVEO Pharmaceuticals Inc., 401(k) Plan filed a Form 5500 for plan year 2023, with Fidelity as recordkeeper.

Signals · 2

Late participant contributionsCorrective distributions issued

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

Colleen Gallagher signed AVEO Pharmaceuticals, Inc.'s 2023 Form 5500 as plan administrator.

Colleen Gallagher — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

AVEO Pharmaceuticals, Inc.'s EIN is 04-3581650.

EIN 04-3581650

Plan number 001

Plan year 2023

ACK ID 20241010091316NAL0020735585001

Official Form 5500 document

Download the official 2023 Form 5500 (PDF) for AVEO Pharmaceuticals, Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2023 Form 5500 (PDF)

Plan features

AVEO Pharmaceuticals, Inc.'s plan includes ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA), profit-sharing.

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for AVEO PHARMACEUTICALS, INC..

Finding similar companies…

How this plan invests

This plan

1 collective trust

Schedule D

Individual securities

on each trust's filing

This plan doesn't hold securities directly — it invests through trusts. Click a trust below to drill into its securities.

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Knocking points off

Delinquent participant contributions reported (Schedule H 4a) — 1K (0% of contributions).
Corrective distributions issued (likely failed ADP/ACP testing).

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
Plan health not scored — no comparable participation/contribution data.

Plan sponsor

Name

AVEO PHARMACEUTICALS, INC.

EIN

all filings

Address

30 WINTER ST. · BOSTON, MA · 02108

Phone

(617) 588-1960

Industry

Professional & Technical Services

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2023

Plan year begin

2023-01-01

Tax period

2023-12-31

Filed

2024-10-10

Pension benefit codes

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

2E · Profit-sharing

Audit & trust (Schedule H)

Service providers (Schedule C)

3 rows

Recordkeeper

Name	EIN	Location	Relation	Direct comp	Indirect comp
FIDELITY INVESTMENTS INSTITUTIONAL	04-2647786	—	RECORDKEEPER	$30K	—

Advisor / Consultant

Name	EIN	Location	Relation	Direct comp	Indirect comp
CAPFINANCIAL PARTNERS, LLC	26-0058143	—	INVESTMENT ADVISOR	$15K	—
STRATEGIC ADVISORS, INC.

Investments

1 pooled fund· $0

Rows tagged as a trust or pooled fund hold many underlying securities. Click one to drill into its own Schedule of Assets — where the individual funds, shares, and CUSIPs live.